IDXX
2024Q2BMOIDEXX Laboratories Inc primary · HEALTHCARE · DIAGNOSTICS & RESEARCH
Street
Consensus EPS2.87
Consensus rev—
EPS high—
EPS low—
Dispersion—
Analysts—
EPS rev net 7d—
EPS rev net 30d—
Consensus Δ 7d—
Consensus Δ 30d—
Options
Implied move3.1%
IV front—
P/C full—
P/C front—
Features as of2024-08-05
Run-up
Close—
Ret 5d-3.7%
Ret 10d-4.3%
Ret 20d-5.9%
Ret 30d-8.2%
Actual EPS
3.02Beat
Estimated EPS2.87
Actual revenue
1.0B
Surprise %+5.2%
Beat / missBeat
Beat streak 44
Beat streak 88
Reaction
1-day stock reaction+0.9%
Implied vs actual
Implied 3.1%Actual 2.2%
Gap reaction+2.2%
Day result+3.1%
Next-day upYes
Realized / IV0.71×
Post tape
Post 5d+3.9%
Post 10d+5.2%
Post volume1.1M
Vol ×10d1.72×
Vol ×20d1.90×
Post range5.2%